nPhase Secures $30 Million in Series D Funding for AI-Native Clinical Data Platform
nPhase has announced it secured $30 million in Series D funding, as reported by Business Wire, citybiz, and HIT Consultant. The company states the capital will be used to drive global expansion and scale its AI-native clinical data platform and agentic workflows for the life sciences industry. This information is primarily based on a company press release.
3 articles from 3 outlets covered this story. The underlying claim is sourced from a press release.
What do all outlets agree on?
3 outlets covered “nPhase Secures $30 Million in Series D Funding for AI-Native Clinical Data Platform”. All of them report the following:
- nPhase secured Series D funding
- The funding amount is $30 million
- The funding is for its AI-native clinical data platform
- The platform is for life sciences
- The purpose includes scaling and global expansion of the platform and agentic workflows
Which outlets covered this?
All 3 articles found on this story, grouped by the stance of the piece. Every link goes to the original publisher.
optimist1
pragmatist2